[68Ga]Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

[68Ga]Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction

Published:2015-12 Issue:12 Volume:8 Page:1466-1468
ISSN:1936-878X
Container-title:JACC: Cardiovascular Imaging
language:en
Short-container-title:JACC: Cardiovascular Imaging

Author:

Lapa Constantin,Reiter Theresa,Werner Rudolf A.,Ertl Georg,Wester Hans-Jürgen,Buck Andreas K.,Bauer Wolfgang R.,Herrmann Ken

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Reference5 articles.

1. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy;Askari;Lancet,2003

2. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells;De Falco;Blood,2004

3. Modulation of CXCR4 expression and SDF-1alpha functional activity during differentiation of human monocytes and macrophages;Gupta;J Leukoc Biol,1999

4. PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent;Gourni;J Nucl Med,2011

5. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction;Zhang;FASEB J,2007

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel tracers to assess myocardial inflammation with radionuclide imaging;Journal of Nuclear Cardiology;2024-07

2. Preclinical Imaging of Cardiovascular Disesase;Seminars in Nuclear Medicine;2023-09

3. [99mTc]Tc-PentixaTec: development, extensive pre-clinical evaluation, and first human experience;European Journal of Nuclear Medicine and Molecular Imaging;2023-08-19

4. In vivo validation of 68Ga-labeled AMD3100 conjugates for PET imaging of CXCR4;Nuclear Medicine and Biology;2023-05

5. Nuclear Medicine Application of Pentixafor/Pentixather Targeting CXCR4 for Imaging and Therapy in Related Disease;Mini-Reviews in Medicinal Chemistry;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3